These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 33578194)

  • 1. Association of the CD2AP locus with cognitive functioning among middle-aged individuals with a family history of Alzheimer's disease.
    Manzali SB; Ravona-Springer R; Alkelai A; Yu E; Gan-Or Z; Ganmore I; Heymann A; Beeri MS; Greenbaum L
    Neurobiol Aging; 2021 May; 101():50-56. PubMed ID: 33578194
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potential contribution of the Alzheimer's disease risk locus BIN1 to episodic memory performance in cognitively normal Type 2 diabetes elderly.
    Greenbaum L; Ravona-Springer R; Lubitz I; Schmeidler J; Cooper I; Sano M; Silverman JM; Heymann A; Beeri MS
    Eur Neuropsychopharmacol; 2016 Apr; 26(4):787-95. PubMed ID: 26947052
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NEDD9 gene polymorphism influences the risk of Alzheimer disease and cognitive function in Chinese older persons.
    Fu Y; He F; Tang NL; Tam CW; Lui VW; Chiu HF; Lam LC
    Alzheimer Dis Assoc Disord; 2012; 26(1):88-90. PubMed ID: 21399483
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In Thai Nationals, the ApoE4 Allele Affects Multiple Domains of Neuropsychological, Biobehavioral, and Social Functioning Thereby Contributing to Alzheimer's Disorder, while the ApoE3 Allele Protects Against Neuropsychiatric Symptoms and Psychosocial Deficits.
    Tangwongchai S; Supasitthumrong T; Hemrunroj S; Tunvirachaisakul C; Chuchuen P; Houngngam N; Snabboon T; Tawankanjanachot I; Likitchareon Y; Phanthumchindad K; Maes M
    Mol Neurobiol; 2018 Aug; 55(8):6449-6462. PubMed ID: 29307083
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Apolipoprotein E moderates the association between non-APOE polygenic risk score for Alzheimer's disease and aging on preclinical cognitive function.
    Xu Y; Sun Z; Jonaitis E; Deming Y; Lu Q; Johnson SC; Engelman CD
    Alzheimers Dement; 2024 Feb; 20(2):1063-1075. PubMed ID: 37858606
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Single-nucleotide polymorphisms of GSK3B, GAB2 and SORL1 in late-onset Alzheimer's disease: interactions with the APOE genotype.
    Izzo G; Forlenza OV; Santos Bd; Bertolucci PH; Ojopi EB; Gattaz WF; Kerr DS
    Clinics (Sao Paulo); 2013; 68(2):277-80. PubMed ID: 23525328
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic Factors Affecting Late-Onset Alzheimer's Disease Susceptibility.
    Rezazadeh M; Khorrami A; Yeghaneh T; Talebi M; Kiani SJ; Heshmati Y; Gharesouran J
    Neuromolecular Med; 2016 Mar; 18(1):37-49. PubMed ID: 26553058
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interaction between two cholesterol metabolism genes influences memory: findings from the Wisconsin Registry for Alzheimer's Prevention.
    Engelman CD; Koscik RL; Jonaitis EM; Okonkwo OC; Hermann BP; La Rue A; Sager MA
    J Alzheimers Dis; 2013; 36(4):749-57. PubMed ID: 23669301
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Both odor identification and ApoE-ε4 contribute to normative cognitive aging.
    Finkel D; Reynolds CA; Larsson M; Gatz M; Pedersen NL
    Psychol Aging; 2011 Dec; 26(4):872-83. PubMed ID: 21517181
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Israel Registry for Alzheimer's Prevention (IRAP) Study: Design and Baseline Characteristics.
    Ravona-Springer R; Sharvit-Ginon I; Ganmore I; Greenbaum L; Bendlin BB; Sternberg SA; Livny A; Domachevsky L; Sandler I; Ben Haim S; Golan S; Ben-Ami L; Lesman-Segev O; Manzali S; Heymann A; Beeri MS
    J Alzheimers Dis; 2020; 78(2):777-788. PubMed ID: 33044181
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alzheimer's disease genes and cognition in the nondemented general population.
    Verhaaren BF; Vernooij MW; Koudstaal PJ; Uitterlinden AG; van Duijn CM; Hofman A; Breteler MM; Ikram MA
    Biol Psychiatry; 2013 Mar; 73(5):429-34. PubMed ID: 22592056
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of apolipoproteins e4 and c1 with onset age and memory: a study of sporadic Alzheimer disease in Taiwan.
    Chuang WL; Hsieh YC; Wang CY; Kuo HC; Huang CC
    J Geriatr Psychiatry Neurol; 2010 Mar; 23(1):42-8. PubMed ID: 20145290
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early onset APOE E4-negative Alzheimer's disease patients show faster cognitive decline on non-memory domains.
    Smits LL; Pijnenburg YA; van der Vlies AE; Koedam EL; Bouwman FH; Reuling IE; Scheltens P; van der Flier WM
    Eur Neuropsychopharmacol; 2015 Jul; 25(7):1010-7. PubMed ID: 25891378
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of Alzheimer's related genotypes with cognitive decline in multiple domains: results from the Three-City Dijon study.
    Vivot A; Glymour MM; Tzourio C; Amouyel P; Chêne G; Dufouil C
    Mol Psychiatry; 2015 Oct; 20(10):1173-8. PubMed ID: 26033242
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of Alzheimer disease family history and genetic risk on cognitive performance in healthy middle-aged and older people.
    Donix M; Ercoli LM; Siddarth P; Brown JA; Martin-Harris L; Burggren AC; Miller KJ; Small GW; Bookheimer SY
    Am J Geriatr Psychiatry; 2012 Jul; 20(7):565-73. PubMed ID: 21849821
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Weighted Genetic Risk Score Based on Four APOE-Independent Alzheimer's Disease Risk Loci May Supplement APOE E4 for Better Disease Prediction.
    Zhang C; Hu R; Zhang G; Zhe Y; Hu B; He J; Wang Z; Qi X
    J Mol Neurosci; 2019 Nov; 69(3):433-443. PubMed ID: 31346968
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A diffusion model analysis of episodic recognition in preclinical individuals with a family history for Alzheimer's disease: The adult children study.
    Aschenbrenner AJ; Balota DA; Gordon BA; Ratcliff R; Morris JC
    Neuropsychology; 2016 Feb; 30(2):225-38. PubMed ID: 26192539
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genome-wide significant risk factors for Alzheimer's disease: role in progression to dementia due to Alzheimer's disease among subjects with mild cognitive impairment.
    Lacour A; Espinosa A; Louwersheimer E; Heilmann S; Hernández I; Wolfsgruber S; Fernández V; Wagner H; Rosende-Roca M; Mauleón A; Moreno-Grau S; Vargas L; Pijnenburg YA; Koene T; Rodríguez-Gómez O; Ortega G; Ruiz S; Holstege H; Sotolongo-Grau O; Kornhuber J; Peters O; Frölich L; Hüll M; Rüther E; Wiltfang J; Scherer M; Riedel-Heller S; Alegret M; Nöthen MM; Scheltens P; Wagner M; Tárraga L; Jessen F; Boada M; Maier W; van der Flier WM; Becker T; Ramirez A; Ruiz A
    Mol Psychiatry; 2017 Jan; 22(1):153-160. PubMed ID: 26976043
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Meta-analysis for genome-wide association study identifies multiple variants at the BIN1 locus associated with late-onset Alzheimer's disease.
    Hu X; Pickering E; Liu YC; Hall S; Fournier H; Katz E; Dechairo B; John S; Van Eerdewegh P; Soares H;
    PLoS One; 2011 Feb; 6(2):e16616. PubMed ID: 21390209
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Apolipoprotein epsilon4 and neuropsychological performance in Alzheimer's disease and vascular dementia.
    McGuinness B; Carson R; Barrett SL; Craig D; Passmore AP
    Neurosci Lett; 2010 Oct; 483(1):62-6. PubMed ID: 20678545
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.